发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF |
摘要 |
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. |
申请公布号 |
CA2751834(A1) |
申请公布日期 |
2010.08.19 |
申请号 |
CA20102751834 |
申请日期 |
2010.02.11 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
EICKELMANN, PETER;MARK, MICHAEL;SEMAN, LEO JOHN;THOMAS, LEO;BROEDL, ULI;GREMPLER, ROLF |
分类号 |
A61K31/00;A61K31/06;A61K31/155;A61K31/198;A61K31/341;A61K31/351;A61K31/39;A61K31/403;A61K31/4439;A61K31/70;A61K31/7004;A61K31/7008;A61P3/06;A61P3/08;A61P3/10 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|